Aesica Pharmaceuticals Limited
Records under this name other than patents Aesica Pharmaceuticals Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Aesica Pharmaceuticals Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,653,139 | Drug substance preparations, pharmaceutical compositions and dosage forms Lapsed on the fee record Ended Feb 18, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 18, 2026 | USPTO record |
| US 6,596,309 | Stable pharmaceutical dosage form for paroxetin anhydrate Lapsed on the fee record Ended Jul 22, 2015 · USPTO record | Lapsed on the fee record | Ended Jul 22, 2015 | USPTO record |
| US 7,838,700 | Recovery and recycling of chiral tartaric acid resolving agents Lapsed on the fee record Ended Nov 23, 2014 · USPTO record | Lapsed on the fee record | Ended Nov 23, 2014 | USPTO record |
| US 6,326,496 | Process for preparing an intermediate in the production of paroxetine Lapsed on the fee record Ended Dec 4, 2013 · USPTO record | Lapsed on the fee record | Ended Dec 4, 2013 | USPTO record |
| US 6,949,650 | Process for the racemization of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2-3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine Lapsed on the fee record Ended Sep 27, 2013 · USPTO record | Lapsed on the fee record | Ended Sep 27, 2013 | USPTO record |
| US 5,599,969 | Process of resolving phenylpropionic acids using .alpha.-methylbenzylamine Term ended Term ended no later than Feb 4, 2017 · Low confidence | Term ended | Term ended no later than Feb 4, 2017 | Low confidence |